Apogee Therapeutics, Inc. APGE Business Segments — Depreciation

Similar metrics at other companies

ULTAReportable Segment Aggregation Before Other Operating — D&A

$81.4M+13.0%

POOLReportable — Depreciation

$11.27M+14.5%

INSMReportable Segment — Depreciation

$2.93M+55.8%

SITMReportable Segment — Depreciation

$4.34M+35.7%

CMCReportable Segment, Aggregation before Other Operating Segment — D&A

$100.21M+47.1%

PRAXReportable Segment — Depreciation expense

$39K-17.0%

Questions, answered.

What is Apogee Therapeutics, Inc.'s business segments — depreciation?

Apogee Therapeutics, Inc. (APGE) reported business segments — depreciation of $408K in Q1 2026.

How has Apogee Therapeutics, Inc.'s business segments — depreciation changed year-over-year?

Apogee Therapeutics, Inc.'s business segments — depreciation increased by 97.1% year-over-year, from $207K to $408K.

What does business segments — depreciation mean?

This metric represents the systematic allocation of the cost of tangible assets over their useful lives within the operating segment. It reflects the consumption of capital equipment and laboratory infrastructure used to support business operations. Higher depreciation indicates a larger investment in physical assets and equipment.